Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Perineural Injection Treatment for Shoulder Pain

NCT: NCT07559058 · COMPLETED

NCT IDNCT07559058
StatusCOMPLETED
Start Date2025-10-01
Completion2026-01-31

Brief Summary

Shoulder pain is a common musculoskeletal condition that can lead to significant functional limitation and reduced quality of life. Conventional treatments often provide limited or temporary relief, highlighting the need for alternative approaches targeting peripheral pain mechanisms. This study aims to evaluate the effectiveness of Perineural Injection Treatment (PIT) compared to Transcutaneous Electrical Nerve Stimulation (TENS) in reducing pain and improving functional outcomes in patients with subacute or chronic shoulder pain. In this randomized controlled trial, participants are assigned to receive either PIT or TENS, in addition to a standardized exercise program. The intervention is delivered over two sessions within a two-week period. Pain intensity is assessed using the Numeric Rating Scale (NRS), and functional outcomes are measured using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. The results of this study are expected to provide evidence on the comparative effectiveness of PIT and TENS, and to support clinical decision-making in the management of shoulder pain.

Frequently Asked Questions

What is Perineural Injection Treatment for Shoulder Pain?

Perineural Injection Treatment for Shoulder Pain is a clinical trial registered under NCT07559058. Current status: COMPLETED.

What is the status of NCT07559058?

The current status of NCT07559058 (Perineural Injection Treatment for Shoulder Pain) is: COMPLETED.

When did Perineural Injection Treatment for Shoulder Pain start?

Perineural Injection Treatment for Shoulder Pain started on 2025-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.